COLSTAR: randomized, open-label, multicentre, phase 3 study comparing futuximab/modotuximab plus trifluridine/tipiracil to trifluridine/tipiracil in KRAS/NRAS and BRAF wild type (wt) metastatic colorectal cancer (mCRC) previously treated with both standard and anti-EGFR treatment
Futuximab;Modotuximab;Trifluridine/Tipiracil;Trifluridine/Tipiracil
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: COLSTAR: randomized, open-label, multicentre, phase 3 study comparing futuximab/modotuximab plus trifluridine/tipiracil to trifluridine/tipiracil in KRAS/NRAS and BRAF wild type (wt) metastatic colorectal cancer (mCRC) previously treated with both standard and anti-EGFR treatment ### Output: Futuximab;Modotuximab;Trifluridine/Tipiracil;Trifluridine/Tipiracil